易方达标普生物科技人民币C(012866)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2022-12-31 | EDIT | Editas Medicine Inc | 买入 | 392.55 | 2.59% |
| 2022-12-31 | BPMC | Blueprint Medicines Corp | 买入 | 379.43 | 2.5% |
| 2022-12-31 | FATE | Fate Therapeutics Inc | 买入 | 378.28 | 2.5% |
| 2022-12-31 | BEAM | Beam Therapeutics Inc | 买入 | 369.31 | 2.44% |
| 2022-12-31 | NTRA | Natera Inc | 买入 | 368.23 | 2.43% |
| 2022-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 买入 | 358.57 | 2.37% |
| 2022-12-31 | CDNA | CareDx Inc | 买入 | 351.47 | 2.32% |
| 2022-12-31 | RLAY | Relay Therapeutics Inc | 买入 | 347.04 | 2.29% |
| 2022-12-31 | AKRO | Akero Therapeutics Inc | 买入 | 341.14 | 2.25% |
| 2022-12-31 | ARWR | Arrowhead Pharmaceuticals Inc | 买入 | 339.28 | 2.24% |
| 2022-12-31 | RXDX | Prometheus Biosciences Inc | 买入 | 338.33 | 2.23% |
| 2022-12-31 | SWTX | SpringWorks Therapeutics Inc | 买入 | 331.08 | 2.19% |
| 2022-12-31 | ALT | Altimmune Inc | 买入 | 330.34 | 2.18% |
| 2022-12-31 | HZNP | Horizon Therapeutics plc | 买入 | 330.96 | 2.18% |
| 2022-12-31 | EBS | Emergent BioSolutions Inc | 买入 | 328.72 | 2.17% |
| 2022-12-31 | CTIC | CTI BioPharma Corp | 买入 | 327.66 | 2.16% |
| 2022-12-31 | RYTM | Rhythm Pharmaceuticals Inc | 买入 | 324.93 | 2.15% |
| 2022-12-31 | EXAS | 精密科学 | 买入 | 323.48 | 2.14% |
| 2022-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 买入 | 324.3 | 2.14% |
| 2022-12-31 | GOSS | Gossamer Bio Inc | 买入 | 316.68 | 2.09% |
公告&资料
